Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

14.10
+0.51003.75%
Volume:461.71K
Turnover:6.46M
Market Cap:241.83M
PE:-1.13
High:14.50
Open:13.68
Low:13.35
Close:13.59
52wk High:31.55
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.90
T/O Rate:3.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:1.09
PE(LYR):-0.97

Loading ...

Tonix Pharmaceuticals - Majority of Enrollment Expected in 2028 Season, May Extend into 2029

THOMSON REUTERS
·
Aug 03

Tonix Pharmaceuticals Posts Investor Deck Focused on Tonmya Fibromyalgia Launch and Pipeline Updates

Reuters
·
Jul 28

Tonix Pharma to Report Q2 Results, Host Conference Call and Webcast

Reuters
·
Jul 27

Tonix Pharma CMO Gregory Sullivan to Retire Aug. 20

Reuters
·
Jul 22

Tonix Pharmaceuticals Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 20

Tonix Pharmaceuticals Investor Deck Spotlights Tonmya Fibromyalgia Launch and Late-stage Pipeline Plans

Reuters
·
Jul 17

Tonix Publishes Journal of Virology Study Showing 2022 Mpox Clade Iib up to 100,000-fold Less Virulent than 2003 Clade Iia

Reuters
·
Jul 15

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

GlobeNewswire
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Tonix Rises on Medicare Coverage Expansion for Chronic Pain Treatment

Reuters
·
Jul 13

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals - Announces Medicare Agreement for Tonmya Adding 9 Mln Lives Effective Jan 1, 2027

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals Posts Investor Deck Spotlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 08

Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)

TIPRANKS
·
Jul 01

Tonix Pharmaceuticals - Enrolls First Patient in Phase 2 Horizon Study of Tnx-102 Sl for Mdd - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Pharmaceuticals - Primary Endpoint is Change in Madrs Total Score at Week 6 - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Enrolls First Patient in Phase 2 Trial of Tnx-102 SL for Major Depressive Disorder

Reuters
·
Jun 29

Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts

TIPRANKS
·
Jun 27

Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James

TIPRANKS
·
Jun 25

Tonix Pharmaceuticals publishes investor deck focused on TONMYA fibromyalgia launch and pipeline programs

Reuters
·
Jun 16